...
首页> 外文期刊>BMC Psychiatry >The SyBil-AA real-time fMRI neurofeedback study: protocol of a single-blind randomized controlled trial in alcohol use disorder
【24h】

The SyBil-AA real-time fMRI neurofeedback study: protocol of a single-blind randomized controlled trial in alcohol use disorder

机译:SyBil-AA实时fMRI神经反馈研究:酒精使用障碍的单盲随机对照试验的方案

获取原文
           

摘要

Alcohol Use Disorder is a highly prevalent mental disorder which puts a severe burden on individuals, families, and society. The treatment of Alcohol Use Disorder is challenging and novel and innovative treatment approaches are needed to expand treatment options. A promising neuroscience-based intervention method that allows targeting cortical as well as subcortical brain processes is real-time functional magnetic resonance imaging neurofeedback. However, the efficacy of this technique as an add-on treatment of Alcohol Use Disorder in a clinical setting is hitherto unclear and will be assessed in the Systems Biology of Alcohol Addiction (SyBil-AA) neurofeedback study. N?=?100 patients with Alcohol Use Disorder will be randomized to 5 parallel groups in a single-blind fashion and receive real-time functional magnetic resonance imaging neurofeedback while they are presented pictures of alcoholic beverages. The groups will either downregulate the ventral striatum, upregulate the right inferior frontal gyrus, negatively modulate the connectivity between these regions, upregulate, or downregulate the auditory cortex as a control region. After receiving 3 sessions of neurofeedback training within a maximum of 2?weeks, participants will be followed up monthly for a period of 3?months and relapse rates will be assessed as the primary outcome measure. The results of this study will provide insights into the efficacy of real-time functional magnetic resonance imaging neurofeedback training in the treatment of Alcohol Use Disorder as well as in the involved brain systems. This might help to identify predictors of successful neurofeedback treatment which could potentially be useful in developing personalized treatment approaches. The study was retrospectively registered in the German Clinical Trials Register (trial identifier: DRKS00010253 ; WHO Universal Trial Number (UTN): U1111–1181-4218) on May 10th, 2016.
机译:饮酒障碍是一种高度流行的精神障碍,给个人,家庭和社会带来沉重负担。酒精使用障碍的治疗具有挑战性,需要新颖新颖的治疗方法来扩大治疗选择范围。实时功能性磁共振成像神经反馈是一种有前途的基于神经科学的干预方法,可以针对皮层以及皮层下大脑过程。但是,该技术作为酒精使用障碍的附加治疗在临床上的功效迄今尚不清楚,将在酒精成瘾的系统生物学(SyBil-AA)神经反馈研究中进行评估。 N≥100的酒精使用障碍患者将以单盲方式随机分为5个平行组,并在向他们展示含酒精饮料的图片时接受实时功能磁共振成像神经反馈。这些组将下调腹侧纹状体,上调右下额回,负面调节这些区域之间的连通性,上调或下调听觉皮层作为控制区域。在最多2周内接受3次神经反馈训练后,将每月对参与者进行3个月的随访,并将复发率作为主要结局指标。这项研究的结果将为实时功能性磁共振成像神经反馈训练在治疗酒精使用障碍以及所涉及的大脑系统中的功效提供真知灼见。这可能有助于确定成功的神经反馈治疗的预测因素,这可能对开发个性化治疗方法很有用。该研究回顾性注册于2016年5月10日在德国临床试验注册簿(试验标识符:DRKS00010253; WHO通用试验编号(UTN):U1111–1181-4218)中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号